These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23906502)

  • 21. Efficacy of intravenous Ig therapy in juvenile dermatomyositis.
    Lam CG; Manlhiot C; Pullenayegum EM; Feldman BM
    Ann Rheum Dis; 2011 Dec; 70(12):2089-94. PubMed ID: 21978999
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Immunosuppressant treatment in refractory myositis. Our experience].
    Danieli MG; Spalletta C; Moretti R; Calabrese V; Marchetti A; Gabrielli A; Logullo F
    Recenti Prog Med; 2009 Oct; 100(10):451-7. PubMed ID: 20030167
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-dose intravenous immunoglobulin exerts its beneficial effect in patients with dermatomyositis by blocking endomysial deposition of activated complement fragments.
    Basta M; Dalakas MC
    J Clin Invest; 1994 Nov; 94(5):1729-35. PubMed ID: 7962520
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Oral lichen planus in a dermatomyositis patient that resolved after intravenous immunoglobulin therapy.
    Geist SM; Tanaka TI
    Oral Surg Oral Med Oral Pathol Oral Radiol; 2014 Oct; 118(4):e111-4. PubMed ID: 25241001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous immunoglobulins in difficult-to-treat ulcerated livedoid vasculopathy: five cases and a literature review.
    Bounfour T; Bouaziz JD; Bézier M; Petit A; Viguier M; Rybojad M; Bagot M
    Int J Dermatol; 2013 Sep; 52(9):1135-9. PubMed ID: 23488633
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Multifocal motor neuropathy: a retrospective study of the response to high-dose intravenous immunoglobulin (IVIg) and current perspectives for diagnosis and treatment].
    Léger JM; Viala K; Maisonobe T; Bouche P
    Bull Acad Natl Med; 2007 Oct; 191(7):1395-407; discussion 1407-9. PubMed ID: 18447061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intravenous immunoglobulins in dermatology. Part 2: clinical indications and outcomes.
    Forbat E; Ali FR; Al-Niaimi F
    Clin Exp Dermatol; 2018 Aug; 43(6):659-666. PubMed ID: 29774587
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of high-dose intravenous immunoglobulin therapy in Japanese patients with steroid-resistant polymyositis and dermatomyositis.
    Saito E; Koike T; Hashimoto H; Miyasaka N; Ikeda Y; Hara M; Yamada H; Yoshida T; Harigai M; Ichikawa Y
    Mod Rheumatol; 2008; 18(1):34-44. PubMed ID: 18217197
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Successful treatment of refractory rash in paraneoplastic amyopathic dermatomyositis.
    Aslanidis S; Pyrpasopoulou A; Kartali N; Zamboulis C
    Clin Rheumatol; 2007 Jul; 26(7):1198-200. PubMed ID: 16779504
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cutaneous ulcers of refractory adult dermatomyositis responsive to intravenous immunoglobulin.
    Peake MF; Perkins P; Elston DM; Older SA; Vinson RP
    Cutis; 1998 Aug; 62(2):89-93. PubMed ID: 9714905
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Calcinosis cutis associated with amyopathic dermatomyositis: response to intravenous immunoglobulin.
    Peñate Y; Guillermo N; Melwani P; Martel R; Hernández-Machín B; Borrego L
    J Am Acad Dermatol; 2009 Jun; 60(6):1076-7. PubMed ID: 19467386
    [No Abstract]   [Full Text] [Related]  

  • 32. Intravenous immunoglobulins as treatment of life threatening esophageal involvement in polymyositis and dermatomyositis.
    Marie I; Hachulla E; Levesque H; Reumont G; Ducrotte P; Cailleux N; Hatron PY; Devulder B; Courtois H
    J Rheumatol; 1999 Dec; 26(12):2706-9. PubMed ID: 10606390
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A nonrandomized comparison of the clinical outcome of ocular involvement in patients with mucous membrane (cicatricial) pemphigoid between conventional immunosuppressive and intravenous immunoglobulin therapies.
    Letko E; Miserocchi E; Daoud YJ; Christen W; Foster CS; Ahmed AR
    Clin Immunol; 2004 Jun; 111(3):303-10. PubMed ID: 15183151
    [TBL] [Abstract][Full Text] [Related]  

  • 34. National registry of patients with juvenile idiopathic inflammatory myopathies in Hungary--clinical characteristics and disease course of 44 patients with juvenile dermatomyositis.
    Constantin T; Ponyi A; Orbán I; Molnár K; Dérfalvi B; Dicso F; Kálovics T; Müller J; Garami M; Sallai A; Balogh Z; Szalai Z; Fekete G; Dankó K
    Autoimmunity; 2006 May; 39(3):223-32. PubMed ID: 16769656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. High-dose intravenous immunoglobulin in inflammatory myopathies: experience based on controlled clinical trials.
    Dalakas MC
    Neurol Sci; 2003 Oct; 24 Suppl 4():S256-9. PubMed ID: 14598055
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Adult dermatomyositis with severe polyneuropathy: does neuromyositis exist?
    Nomura M; Watanabe T; Mikami H; Ishikawa H; Yasui K; Yamazaki T; Irie T; Suzuki M; Ono S
    Neurol Sci; 2010 Jun; 31(3):373-6. PubMed ID: 20229079
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Steroid sparing effect of intravenous immunoglobulin therapy in patients with pemphigus foliaceus.
    Sami N; Qureshi A; Ahmed AR
    Eur J Dermatol; 2002; 12(2):174-8. PubMed ID: 11872417
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis of current data on the use of intravenous immunoglobulins in management of pemphigus vulgaris.
    Engineer L; Bhol KC; Ahmed AR
    J Am Acad Dermatol; 2000 Dec; 43(6):1049-57. PubMed ID: 11100022
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Treatment of epidermolysis bullosa acquisita with intravenous immunoglobulin in patients non-responsive to conventional therapy: clinical outcome and post-treatment long-term follow-up.
    Ahmed AR; Gürcan HM
    J Eur Acad Dermatol Venereol; 2012 Sep; 26(9):1074-83. PubMed ID: 21819451
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Usefulness of high-dose intravenous human immunoglobulins treatment for refractory recurrent pericarditis.
    Moretti M; Buiatti A; Merlo M; Massa L; Fabris E; Pinamonti B; Sinagra G
    Am J Cardiol; 2013 Nov; 112(9):1493-8. PubMed ID: 23972350
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.